Glaston wrote: Fri Apr 09, 2021 6:22 am
The Halix plant in Holland.
All those reports last week of it being seed funded by the UK. £20 something million was the figure.
“In the discussion I had at the beginning with the CEO of AstraZeneca, I understood, he told me, that the ramp up of Halix has been financed by the British government,” Breton said. “And it happens that when I went to visit the site and I asked how much they’re received from the British government, the chairman and the CEO were there and they told me ‘zero’. So in fact, I asked three times a question and I got three times the same answer.”
That's Thierry Breton the EU's vaccine commissar.
https://www.theguardian.com/world/2021/ ... s-brussels
Odd!
What I haven't seen yet is realistic speculation on why it took so long for the plant's EMA authorisation application to get submitted in March, as Saint mentioned earlier in the thread MHRA signed-off last year.
Given the EU commissions' willingness to openly critique AZ, I would speculate the lack of it criticism here has something to do EU side re delayed funding to enable the plant to adjust for EMA approval (given EMA sign-off was done same month). Though I can't imagine these are terribly different from what the MHRA would have. All very odd.
Only speculation I have seen were muppet cries that the plant delayed so it could supplement UK production, which doesn't pass the sniff test and would have been called out.
As for Breton's unsubtle comments hinting they are being kind not to blackmail UK in completing dosing regimes or the 70% completion is better than our current strategy
Not that all member states+NO+IS will achieve 70% anyway, here is a Bloomberg chart reportedly on an EU memo re full dosing regimes delivered (not administered) by June end. Realistically only the Nordics + small states could do so given they traded with member states for more Pfizer jabs over AZ, but so long as Norway/Denmark have blanket suspensions or age recommendations on the latter they won't make it either. Should shut the rhetoric and focus on touting increased production over export bans, success in getting J&J to bottle in Europe rather than US and getting the Balkan states to use what they are being given.
